Capture

PRODUCTS

  • This easy-to-use process analytical technology device offers in-line bioprocess analysis and control with no complex modeling. Measure multiple critical parameters across media, across processes, across mammalian cell lines, across scales.

    All In-line Gain, No Modeling Pain

    MAVERICK is powered by Raman spectroscopy and a purpose-built de novo model. The de novo model is explicitly built on media chemistries and device physics, not on empirical data. It automatically interprets the spectra and quantifies process parameters enabling simultaneous measurements of glucose, lactate, and total biomass. This is achieved without the costs, complexities, and risks associated with conventional Process Analytical Technology (PAT) methods. There is no need to grapple with complex empirical models, reagents, or unreliable auto-sampling systems to implement in-line bioprocess analysis.

  • Optimize single-use solutions for cryopreservation by engaging in studies that focus on specific timepoints and conditions pertaining to therapy storage, containment/protection, and transportation.

  • Mikart offers a wide range of bottle filling options personalized to your needs.

  • Navigating both the specific country and general European regulations and requirements to supply medicinal products to the European markets can be a complex challenge. This applies both to Marketing Authorisation Holders (MAH) of approved commercial medicinal products and Sponsors of clinical trials.

  • A Transfection Solution for Gram-Scale Protein Production

    The ExPERT VLx system delivers unmatched transfection scalability with MaxCyte's Flow Electroporation® technology for industry-leading reproducibility, flexibility and ease of use.

    • Reduce time, cost and risk
    • Transfect up to 200 billion cells, in a single-use system, in less than 30 minutes
    • Obtain grams of proteins in weeks, not months
    • Achieve reproducible results, superior transfection efficiency, cell viability and protein expression
    • Scale seamlessly to expedite your transition from discovery to Phase 1
    • Proprietary Flow Electroporation® Technology

WHITE PAPERS AND CASE STUDIES

NEWS